The Estee Lauder Companies Inc.’s “Beauty Reimagined” makeover – the largest operational transformation in the company’s history – sets out to create a “flatter and leaner” organization, while tripling innovation each year and scaling AI integration across the business.
Estee Lauder’s Biggest Makeover Should Triple Innovation, Create ‘Flatter and Leaner’ Biz – CEO
New Estee Lauder President and CEO Stéphane de La Faverie unveils "Beauty Reimagined" restructuring effort to expand its recovery plan and unleash innovation to restore sustainable sales growth over next few years. The largest operational transformation in its history will include cutting up to 7,000 jobs and total charges of $1.2bn-$1.6bn, while grossing annual savings of $800m-$1bn.
More from HBW Insight
• By
Ibis Reproductive Health adds Desiree Williams to lead MORE Study; Radicle Science adds Rob Sinnott as senior strategic advisor; Leann Sims joins AbundaBox as COO; former Cannabis Beverage Association president moves to Vertosa; Vegamour expands executive staff with CMO; and Oura Ring firm appoints CMO.
• By
Arkopharma's parent company Dermapharm is undertaking a strategic shift at the French firm to help it better compete in the dietary supplements market after a tough year.
• By
Single-use packaging producers subject to California’s SB 54 recycling law, which implements a statewide EPR plan, should continue to prepare for its implementation, even as they enter a ‘prolonged period of uncertainty,’ says consultant Michael Washburn.
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
More from Strategy
• By
New Estee Lauder President and CEO Stéphane de La Faverie unveils "Beauty Reimagined" restructuring effort to expand its recovery plan and unleash innovation to restore sustainable sales growth over next few years. The largest operational transformation in its history will include cutting up to 7,000 jobs and total charges of $1.2bn-$1.6bn, while grossing annual savings of $800m-$1bn.
• By
Egis is the beneficiary as Teva again trims its OTC portfolio with the sale of Hungarian skin-care brand Neogranormon.
• By
Kenvue's EMEA and LATAM head Carlton Lawson acknowledges the urgency of environmental issues like antimicrobial resistance and wastewater pollution in this interview with HBW Insight, but calls for a more balanced approach on the part of European regulators.